TEG 6s® for Perioperative Monitoring of Platelet Function During Cardiopulmonary Bypass for Cardiac Surgery

Stopped Haemonetics, the company that manages the TEG device, has given a negative answer as to the continuation of the study. For technical and internal reasons, they will take over the device.

Conditions

• Cardiopulmonary Bypass

Interventions

• DEVICE: TEG®6S device with its Platelet mapping® cartridge

Sponsor

Assistance Publique - Hôpitaux de Paris